Assyro AI

Orange Book product · Brand (NDA)

ZOLPIMIST

ZOLPIDEM TARTRATE

Brand (NDA)NDA 022196DISCN AYTU

At a glance

Dec 19, 2008

Approved

Brand (NDA)

Application

Not listed

TE code

1

Listed patents

Key dates

  1. Approval

    FDA approval date of this drug product.

    Dec 19, 2008

    17 yr 9 mo ago

  2. Today

  3. Patent 8236285 expires

    Listed drug substance patent expiration.

    Aug 07, 2032

    in 6 yr 3 mo

Pharmaceutical detail

Active ingredient

ZOLPIDEM TARTRATE

Strength

5MG/SPRAY

Dosage form

SPRAY, METERED

Route

ORAL

TE code

Not listed

Application

NDA 022196

Product number

001

Marketing status

DISCN

Reference listed drug (RLD)

Yes

Reference standard (RS)

No

Active-ingredient family

View full family

This is a reference-listed drug (RLD) — the basis for generic (ANDA) applications. Other products sharing this ingredient are listed below.

Listed patents (1)

Patents listed in the FDA Orange Book for this product, with expiration date and patent type.
PatentExpiresInType
8236285Aug 07, 2032in 6 yr 3 mo
SubstanceProductU-70
Agent CTA Background

Your Next Submission Could Take 6+ Fewer Weeks and Cost $250K Less.